Medicare characteristics, treatment, cost and survival in triple class exposed relapsed or refractory multiple myeloma

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Trends in overall survival and costs of multiple myeloma, 2000–20142016 · 330 citations
2. 2Novel Approaches to Treatment of Double-Refractory Multiple Myeloma2013 · 15 citations
3. 3Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data2005 · 10,691 citations
4. 4Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?2019 · 160 citations
5. 5Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies2018 · 52 citations